| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/26/2012 | US20120022141 Compositions and methods for inhibiting expression of a gene from the jc virus |
| 01/26/2012 | US20120022136 Cellular Genes Regulated by HIV-1 Infection and Methods of Use Thereof |
| 01/26/2012 | US20120022123 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof |
| 01/26/2012 | US20120022120 Antimycotic pharmaceutical composition |
| 01/26/2012 | US20120022113 Methods for suppressing tipdc trafficking or accumulation and preventing hypercytokinemia |
| 01/26/2012 | US20120022107 2-(piperidin-1-yl)-4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections |
| 01/26/2012 | US20120022092 Protein kinase c inhibitors and uses thereof |
| 01/26/2012 | US20120022081 Method of using diketopiperazines and composition containing them |
| 01/26/2012 | US20120022079 Method For Producing Preparations Of Substances Poorly Soluble In Water |
| 01/26/2012 | US20120022076 Derivatives of n-(arylamino)sulfonamides as inhibitors of mek |
| 01/26/2012 | US20120022073 Compound for the treatment of enteroviruses |
| 01/26/2012 | US20120022068 NOVEL HETEROCYCLIC NF-kB INHIBITORS |
| 01/26/2012 | US20120022062 Flavanoid Compounds and Process for Preparation Thereof |
| 01/26/2012 | US20120022061 Benzo [c] phenanthridines as antimicrobial agents |
| 01/26/2012 | US20120022059 Substituted furancarboxamides, and use thereof |
| 01/26/2012 | US20120022054 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents |
| 01/26/2012 | US20120022052 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 01/26/2012 | US20120022048 Anti-proliferative substituted pyrazolo[3,4-d]pyrimidines derivatives (SPP) to inhibit immune activation, virus replication and tumor growth |
| 01/26/2012 | US20120022046 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
| 01/26/2012 | US20120022045 Bridged compounds as hiv integrase inhibitors |
| 01/26/2012 | US20120022040 Antimicrobials |
| 01/26/2012 | US20120022038 Animal treatment formulation and methods of use |
| 01/26/2012 | US20120022037 Aqueous hair cleansing agent |
| 01/26/2012 | US20120022031 Composition and methods of treatment of bacterial meningitis |
| 01/26/2012 | US20120022027 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| 01/26/2012 | US20120022025 Crystalline form c of tigecycline dihydrochloride and methods for its preparation |
| 01/26/2012 | US20120022024 Anti-bacterial compositions and methods including targeting virulence factors of staphylococcus aureus |
| 01/26/2012 | US20120022023 Hydraulic Cements, Methods and Products |
| 01/26/2012 | US20120022018 Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment |
| 01/26/2012 | US20120022010 Use of flavonoids to increase the bioavailability of hesperetin |
| 01/26/2012 | US20120022003 Method of using diketopiperazines and composition containing them |
| 01/26/2012 | US20120022001 Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle |
| 01/26/2012 | US20120021975 Antibiotic peptides |
| 01/26/2012 | US20120021470 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 01/26/2012 | US20120021079 Garcinia Mangostana L. and Iridoid Based Formulations |
| 01/26/2012 | US20120021073 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with dhea for the treatment of smallpox |
| 01/26/2012 | US20120021071 Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis |
| 01/26/2012 | US20120021061 Medical and nutritional formulations |
| 01/26/2012 | US20120021060 Honey Compositions and Uses Thereof |
| 01/26/2012 | US20120021053 Controlled release and taste-masking oral pharmaceutical composition |
| 01/26/2012 | US20120021050 Nanoparticle formulated glycolipid antigens for immunotherapy |
| 01/26/2012 | US20120021038 Coating composition |
| 01/26/2012 | US20120021033 DISPERSIN B POLYNUCLEOTIDES AND METHODS OF PRODUCING RECOMBINANT DspB POLYPEPTIDES |
| 01/26/2012 | US20120021014 Corrosion current-generating metal particulates and use thereof |
| 01/26/2012 | US20120021007 Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
| 01/26/2012 | US20120021005 Mycoplasma gallisepticum formulation |
| 01/26/2012 | US20120021004 Medium and method of deriving and using a mutated bacteria strain |
| 01/26/2012 | US20120021003 Vaccine for protection against streptococcus suis bacteria of various serotypes |
| 01/26/2012 | US20120021000 HIV DNA Vaccine Methods of Use |
| 01/26/2012 | US20120020999 DNA Vaccine Compositions with HIV/SIV Gene Modifications |
| 01/26/2012 | US20120020998 Plasmacytoid dendritic cell line used in active or adoptive cell therapy |
| 01/26/2012 | US20120020997 Multi plasmid system for the production of influenza virus |
| 01/26/2012 | US20120020996 Vaccines against clostridium difficile and methods of use |
| 01/26/2012 | US20120020995 Parapoxvirus vectors |
| 01/26/2012 | US20120020994 Multivalent, drying resistant, evolution-based vaccines |
| 01/26/2012 | US20120020986 Antibodies to the PcrV Antigen of Pseudomonas aeruginosa |
| 01/26/2012 | US20120020980 High affinity human antibodies to human cytomegalovirus (cmv) gb protein |
| 01/26/2012 | US20120020973 Chimeric ospa genes, proteins, and methods of use thereof |
| 01/26/2012 | US20120020971 Antibodies useful in passive influenza immunization |
| 01/26/2012 | US20120020969 Compositions And Methods For Inhibiting Viral Adhesion |
| 01/26/2012 | US20120020965 Molecules that bind CD180, compositions and methods of use |
| 01/26/2012 | US20120020964 Antibodies for Norovirus |
| 01/26/2012 | US20120020963 Anti-inteferon alpha monoclonal antibodies and methods for use |
| 01/26/2012 | US20120020962 Method of depleting regulatory t cell |
| 01/26/2012 | US20120020957 Dengue virus neutralizing antibodies and use thereof |
| 01/26/2012 | US20120020950 Antibacterial compounds |
| 01/26/2012 | US20120020943 Lactobacillus Plantarum and Uses Thereof |
| 01/26/2012 | US20120020942 Novel Lactobacillus Strains And Their Use Against Helicobacter Pylori |
| 01/26/2012 | US20120020941 Use of blood group status iii |
| 01/26/2012 | US20120020940 Antimicrobial peptides |
| 01/26/2012 | US20120020923 Method of treating viral diseases with combinations of TPO receptor agonist and anti-viral agents |
| 01/26/2012 | US20120020922 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 01/26/2012 | US20120020921 1'-substituted-carba-nucleoside prodrugs for antiviral treatment |
| 01/26/2012 | US20120020920 5-5-membered fused heterocyclic compound and use thereof as hcv polymerase inhibitor |
| 01/26/2012 | US20120020919 Methods for treating viral infection using il-28 and il-29 |
| 01/26/2012 | US20120020914 Leukemia inhibitory factor (lif) for use in repressing human papillomavirus (hpv) transcription |
| 01/26/2012 | US20120020897 Dentifrice composition |
| 01/26/2012 | US20120020895 Bear bile macromolecular extract and preparation method and use thereof |
| 01/26/2012 | US20120020890 Staphylococcus aureus proteins and nucleic acids |
| 01/26/2012 | US20120020885 MHC-Less cells |
| 01/26/2012 | US20120018334 Conjugated antimicrobial agents |
| 01/26/2012 | US20120017892 Use of salt of an acetylsalicylic acid for the treatment of viral infections |
| 01/26/2012 | CA2809405A1 Compounds for photodynamic therapy |
| 01/26/2012 | CA2806476A1 Substituted indoles, antiviral active component, method for producing and using same |
| 01/26/2012 | CA2806362A1 Administration of rifalazil to immunocompromised patients |
| 01/26/2012 | CA2806258A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | CA2806250A1 Cross-protective pathogen protection, methods and compositions thereof |
| 01/26/2012 | CA2806111A1 An ancestral serine protease coagulation cascade exerts a novel function in early immune defense |
| 01/26/2012 | CA2806108A1 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 01/26/2012 | CA2805962A1 Crystal of peptide substance as well as the preparation method and use thereof |
| 01/26/2012 | CA2805824A1 Compositions comprising derivatives of essential oil compounds and use in personal care products |
| 01/26/2012 | CA2805745A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 01/26/2012 | CA2805741A1 Influenza vaccine |
| 01/26/2012 | CA2804622A1 Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment |
| 01/26/2012 | CA2768866A1 High yield yellow fever virus strain with increased propagation in cells |
| 01/25/2012 | EP2409966A1 Aminocyclitol compounds, procedure for the obtainment and uses |
| 01/25/2012 | EP2409706A1 Dihydropteridinones for the treatment of cancer diseases |
| 01/25/2012 | EP2409699A1 Stable compositions of voriconazole |
| 01/25/2012 | EP2408779A1 Compounds and biological materials and uses thereof |
| 01/25/2012 | EP2408770A2 Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials |